Professional investor Daniel Koller picks three cutting edge three biotech stocks to buy now.
Articles written by Daniel Koller
Professional investor Daniel Koller picks six stocks to profit from the continuing biotech boom.
Professional investor Dr Daniel Koller picks five innovative biotech stocks to buy now.
The recent correction in biotech stocks was overdone, says professional investor Dr Daniel Koller. Here, he picks four biotech companies to buy now.
Biotechnology firms are benefiting from demand from ageing populations. But as Dr Daniel Koller explains, there’s more to the biotech boom than that.
Investors can find a wide range of profitable stocks in the biotech sector. Professional investor Dr Daniel Koller tips three to buy now.